MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

Myomo Inc

Fechado

0.91 -3.19

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.9

Máximo

0.95

Indicadores-chave

By Trading Economics

Rendimento

969K

-3.7M

Vendas

438K

10M

Margem de lucro

-36.3

Funcionários

184

EBITDA

1.1M

-3.1M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+486.73% upside

Dividendos

By Dow Jones

Próximos Ganhos

9 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

5.1M

38M

Abertura anterior

4.1

Fecho anterior

0.91

Myomo Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de jan. de 2026, 22:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 de jan. de 2026, 00:00 UTC

Ganhos

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 de jan. de 2026, 23:47 UTC

Conversa de Mercado

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 de jan. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 de jan. de 2026, 23:39 UTC

Conversa de Mercado

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 de jan. de 2026, 23:32 UTC

Conversa de Mercado

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 de jan. de 2026, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 de jan. de 2026, 22:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

14 de jan. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 de jan. de 2026, 22:09 UTC

Ganhos

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 de jan. de 2026, 22:08 UTC

Ganhos

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 de jan. de 2026, 21:53 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 de jan. de 2026, 21:52 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Announces Positive Profit Alert for 2025

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Citigroup Acting as Financial Advisor to WuXi XDC

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 de jan. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

14 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

14 de jan. de 2026, 21:49 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 de jan. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

WuXi XDC Makes Cash Offer for BioDlink International

14 de jan. de 2026, 21:13 UTC

Conversa de Mercado

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 de jan. de 2026, 20:30 UTC

Conversa de Mercado
Ganhos

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 de jan. de 2026, 20:13 UTC

Conversa de Mercado

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 de jan. de 2026, 20:08 UTC

Conversa de Mercado

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 de jan. de 2026, 19:33 UTC

Conversa de Mercado

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 de jan. de 2026, 19:06 UTC

Conversa de Mercado
Ganhos

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparação entre Pares

Variação de preço

Myomo Inc Previsão

Preço-alvo

By TipRanks

486.73% parte superior

Previsão para 12 meses

Média 5.75 USD  486.73%

Máximo 10 USD

Mínimo 4 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Myomo Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

5 ratings

5

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
help-icon Live chat